Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cyclo(arg-gly-asp-d-phe-val) (cyclic pentapeptide crgdfv) in China, also supports custom service. Welcome to wholesale bulk high quality cyclo(arg-gly-asp-d-phe-val) (cyclic pentapeptide crgdfv) from our factory. Contact us for more details.
| Description | Cyclo(Arg-Gly-Asp-D-Phe-Val) (cRGDfV, CAS: 137813-35-5) is a head-to-tail cyclic pentapeptide composed of arginine (Arg, R), glycine (Gly, G), aspartic acid (Asp, D), D-phenylalanine (D-Phe, f), and valine (Val, V), with RGD (Arg-Gly-Asp) as the core recognition motif. The cyclic structure and the introduction of D-phenylalanine significantly enhance the peptide's binding affinity, selectivity for αvβ3 integrin, and resistance to proteolytic degradation. αvβ3 integrin is highly expressed on tumor vascular endothelial cells and various tumor cell surfaces, playing critical roles in tumor angiogenesis, invasion, and metastasis. cRGDfV competitively binds to αvβ3 integrin, blocking its interaction with extracellular matrix ligands (e.g., fibronectin, vitronectin), thereby inhibiting tumor angiogenesis and tumor cell invasion/metastasis, exhibiting antitumor activity. cRGDfV is widely used as a tumor-targeting ligand for modifying nanoparticles, liposomes, polymeric micelles, and imaging probes to achieve tumor-targeted drug delivery and molecular imaging, with applications in acute myeloid leukemia and other cancer research. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) | Cyclic RGD pentapeptide; c(RGDfV); cyclic Arg-Gly-Asp-D-Phe-Val peptide | Integrin antagonist peptide, tumor targeting, anti-angiogenesis, cell adhesion regulation | Head-to-tail cyclized pentapeptide with an RGD core recognition motif; D-phenylalanine locks the active conformation, significantly enhancing integrin binding affinity and protease resistance | C₂₆H₃₈N₈O₇ | 578.29 | ~578.7 | Trifluoroacetate (TFA) | 5 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-CRD005 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. TFA salt is soluble in water, dilute acetic acid and DMSO. Cyclic structure significantly improves protease resistance with good stability over a wide pH range; cyclic peptide bond prone to cleavage under strong alkaline conditions. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-CRD005 | Cyclic RGDfV pentapeptide antagonizes integrins with high affinity for anti-angiogenic tumor targeting | Cyclo(Arg-Gly-Asp-D-Phe-Val) is a classic highly active integrin antagonist peptide. Cyclization and D-phenylalanine lock the RGD motif in optimal active conformation, resulting in much higher binding affinity for integrins αvβ₃ and α5β₁ than linear RGD peptides. It competitively blocks integrin-mediated cell adhesion, migration and angiogenic signaling, and inhibits tumor angiogenesis, invasion and metastasis. | Tumor targeted therapy, anti-angiogenesis research, integrin biology, targeted drug development, cell adhesion regulation | Integrins αvβ₃ / α5β₁; RGD competitive antagonism; cell adhesion & migration pathway |
Hot Tags: cyclo(arg-gly-asp-d-phe-val) (cyclic pentapeptide crgdfv), China cyclo(arg-gly-asp-d-phe-val) (cyclic pentapeptide crgdfv) manufacturers, suppliers, factory, 203716-10-3, 651328-78-8, drug delivery peptides, MPG Peptide, Tetralysine, therapeutic and pharmaceutical peptides
